Implantable islet cells could control diabetes without insulin injections
The cells can survive in the body for at least three months, producing enough insulin to control blood sugar levels, research shows.
The cells can survive in the body for at least three months, producing enough insulin to control blood sugar levels, research shows.
Anthropologist Amy Moran-Thomas studies overlooked insights from people health care is meant to reach.
MIT engineers show they can accurately measure blood glucose by shining near-infrared light on the skin.
The new implant carries a reservoir of glucagon that can be stored under the skin and deployed during an emergency — with no injections needed.
Watery fluid between cells plays a major role, offering new insights into how organs and tissues adapt to aging, diabetes, cancer, and more.
The prestigious fellowship, which honors independence of thought, purposeful leadership, and civic mindset, funds graduate studies at Stanford University.
Chronic diseases like diabetes are prevalent, costly, and challenging to treat. A common denominator driving them may be a promising new therapeutic target.
Awarded $65.67 million from ARPA-H, the researchers will work to develop ingestible capsules that deliver mRNA and electric stimuli to treat metabolic disorders such as diabetes.
Researchers can use the model to predict how engineered forms of insulin would perform in human patients, making it easier to bring these drugs to clinical trials.
The device contains encapsulated cells that produce insulin, plus a tiny oxygen-producing factory that keeps the cells healthy.
Payton Dupuis finds new scientific interests and career opportunities through MIT summer research program in biology.
A new device, which doesn’t rely on immunosuppressing drugs, may assist efforts to develop an artificial pancreas to treat diabetes.
The MIT anthropologist is recognized for interdisciplinary work on health, climate, and equity.
MIT anthropologist Amy Moran-Thomas reflects on the deep connection between planetary and human well-being.
Chemical engineers have developed a way to protect transplanted drug-producing cells from immune system rejection.